Analysis on Bevacizumab with PDT for CSC

Analysis on Bevacizumab with PDT for CSC

AIM: To study the influence of intravitreal injection of bevacizumab combined with photon dynamic treatment(PDT)in the treatment of central serous choroiretinopathy(CSC). <p>METHODS:We selected 82 CSC patients treated in the hospital between February 2012 and April 2015, who were diagnosed by...

Full description

Bibliographic Details
Main Authors:	Min Yang, Xu-Guang Jiang, Yan-Long Li, Xiao-Dong Han
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2018-05-01
Series:	Guoji Yanke Zazhi
Subjects:	central serous choroiretinopathy vitreous injection bevacizumab photon dynamic treatment clinical efficacy
Online Access:	http://ies.ijo.cn/cn_publish/2018/5/201805028.pdf

Similar Items

Effect of Intravitreal Injection of Bevacizumab on Acute Central Serous Chorioretinopathy Patients who Visited Feiz Hospital during 2014–2015 Period
by: Mohamad Reza Akhlaghi, et al.
Published: (2017-01-01)

Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
by: Tianqing Chu, et al.
Published: (2021-08-01)

Changes in the Choroidal Thickness following Intravitreal Bevacizumab Injection in Chronic Central Serous Chorioretinopathy
by: Yoo-Ri Chung, et al.
Published: (2022-06-01)

Intravitreal Bevacizumab (Avastin) in Treatment of Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy
by: Attaullah Shah Bukhari, et al.
Published: (2018-06-01)

Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy
by: Maria G. Kotoula, et al.
Published: (2012-06-01)

Efficacy of Bevacizumab Combined with Pemetrexed in the Treatment of Recurrent and Metastatic Cervical Cancer
by: Ying He, et al.
Published: (2022-05-01)

Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy
by: Tsubota K, et al.
Published: (2019-06-01)

Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus
by: Beuy Joob, et al.
Published: (2017-03-01)

Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization
by: Hongjie Mu, et al.
Published: (2018-01-01)

Intravitreal bevacizumab for treatment of central serous chorioretinopathy
by: Cihan Ünlü, et al.
Published: (2016-01-01)

Hemorrhagic Macular Infarction after Intravitreal Bevacizumab for Chronic Multifocal Central Serous Chorioretinopathy
by: Aditya Kelkar, et al.
Published: (2014-07-01)

Bevacizumab for non-small cell lung cancer patients with brain metastasis: A meta-analysis
by: Liang Ping, et al.
Published: (2020-07-01)

The Effect of Metabolic Diseases on the Outcome of Bevacizumab Injection for Central Serous Retinopathy
by: M Babaei, et al.
Published: (2022-03-01)

Study on intraocular permeability of Bevacizumab after retrobulbar Tenon capsule perfusion in rabbits
by: Yi-Nan Wu, et al.
Published: (2015-09-01)

Clinical study on Bevacizumab for macular edema induced by retinal vein occlusion
by: Zhi-Guang Duan, et al.
Published: (2014-09-01)

Post intravitreal bevacizumab recurrent Burkholderia cepacia endophthalmitis treated with clear lens extraction in an African
by: Ogugua Ndubuisi Okonkwo, et al.
Published: (2020-12-01)

Meta-analysis of efficacy and safety of bevacizumab in the treatment of hereditary hemorrhagic telangiectasia epistaxis
by: Huimin Chen, et al.
Published: (2023-12-01)

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects
by: Cengiz Alagöz, et al.
Published: (2016-10-01)

Systemic bevacizumab for pediatric patients with aggressive recurrent respiratory papillomatosis: One single‐center experience of eight patients
by: Zengjun Liu, et al.
Published: (2023-04-01)

Intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization
by: Farhad Fazel Najafabadi, et al.
Published: (2015-01-01)

Efficacy and Safety of Different Doses of Bevacizumab Combined With Pemetrexed and Platinum in First-Line Treatment of Advanced NSCLC: A Retrospective-Real World Study
by: Chun-Hua Zhou, et al.
Published: (2021-11-01)

Intravitreal Bevacizumab May Increase Diabetic Macular Edema in Eyes with Attached Posterior Vitreous
by: Mustafa Ozsutcu, et al.
Published: (2013-01-01)

Subconjunctival Bevacizumab Injection in Treatment of Pterygium
by: Mohammad Reza Besharati, et al.
Published: (2011-03-01)

Subconjunctival Bevacizumab Injection in Treatment of Pterygium
by: Mohammad Reza Besharati, et al.
Published: (2011-03-01)

Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma
by: Zanuso V, et al.
Published: (2023-10-01)

Central incisor extraction orthodontic treatment of anterior tooth openbite: a case report
by: Zhou Jiayao, Xu Yuhong, Feng Jing
Published: (2022-02-01)

Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab
by: Xuting Hu, et al.
Published: (2019-09-01)

Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats
by: Yan Lu, et al.
Published: (2014-02-01)

Corneal thinning following bevacizumab intrastromal injection for the treatment of idiopathic lipid keratopathy
by: Kristie J. Sun, et al.
Published: (2022-09-01)

Clinical observation of bevacizumab(avastin)for treating age-related macular degeneration
by: Zhi-Guang Duan, et al.
Published: (2014-06-01)

Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non‐small cell lung cancer: A randomized, double‐blind, phase III study
by: Likun Chen, et al.
Published: (2023-11-01)

Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
by: Srikant Padhy, et al.
Published: (2018-01-01)

Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital
by: Santosh Ramesh, et al.
Published: (2022-01-01)

Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study
by: Xin Yu, et al.
Published: (2018-05-01)

Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
by: Fenge Jiang, et al.
Published: (2022-09-01)

Bevacizumab Treatment for Low-Grade Serous Ovarian Cancer: A Systematic Review
by: Caitlin Lazurko, et al.
Published: (2023-09-01)

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study
by: Zhao C, et al.
Published: (2023-07-01)

The Short-Term Effect of Intravitreal Bevacizumab Injection on Intraocular Pressure
by: Şehnaz Özçalışkan, et al.
Published: (2014-10-01)

Bevacizumab: Off-label use in ophthalmology
by: Grisanti Salvatore, et al.
Published: (2007-01-01)

Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumab
by: Shenglin Li, et al.
Published: (2023-03-01)